{
  "data": {
    "id": "org_national-center-for-science-and-engineering-statistics",
    "slug": "national-center-for-science-and-engineering-statistics",
    "name": "National Center for Science and Engineering Statistics",
    "short_name": "NCSES",
    "type": "government",
    "tier": 1,
    "homepage": "https://ncses.nsf.gov",
    "country_code": "US",
    "reliability_note": null,
    "url": "https://statorigin.org/sources/national-center-for-science-and-engineering-statistics",
    "documents": [
      {
        "title": "Business R&D Performance in the United States Increases to $722 Billion in 2023",
        "url": "https://ncses.nsf.gov/pubs/nsf25353",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 8
      },
      {
        "title": "Discovery: R&D Activity and Research Publications",
        "url": "https://ncses.nsf.gov/pubs/nsb20257/u-s-business-r-d",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 3
      }
    ],
    "statistics": [
      {
        "id": "stat_VWSC69XR085KDC13XQAD65FJY0",
        "url": "https://statorigin.org/stat/stat_VWSC69XR085KDC13XQAD65FJY0",
        "indicator": {
          "slug": "pharmaceutical-and-medicine-manufacturing-r-d-funded-by-domestic-companies",
          "name": "Pharmaceutical and medicine manufacturing R&D funded by domestic companies",
          "definition": "Cost of research and development performed by pharmaceutical and medicine manufacturing companies that was paid for by other domestic companies."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2023-01-01",
          "end": "2023-12-31",
          "type": "year"
        },
        "value": 2104,
        "value_text": "2,104",
        "unit": "USD",
        "currency": "USD",
        "scale": "million",
        "value_type": "actual",
        "source": {
          "org": "National Center for Science and Engineering Statistics",
          "org_short_name": "NCSES",
          "org_url": "https://ncses.nsf.gov",
          "org_tier": 1,
          "document_title": "Business R&D Performance in the United States Increases to $722 Billion in 2023",
          "document_url": "https://ncses.nsf.gov/pubs/nsf25353",
          "document_type": "press_release",
          "locator": "Table 2. Funds spent for business R&D performed in the United States, by source of funds, selected industry, and company size: 2023",
          "quote": "Pharmaceuticals and medicines, 3254 125,986 empty 114,225 empty 11,761 empty 549 empty 2,104 empty 9,029 empty 79 empty",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "National Center for Science and Engineering Statistics. (2023). Business R&D Performance in the United States Increases to $722 Billion in 2023. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsf25353. Via StatOrigin, https://statorigin.org/stat/stat_VWSC69XR085KDC13XQAD65FJY0",
          "bibtex": "@misc{ncses2023pharmaceutical65fjy0,\n  author       = {{National Center for Science and Engineering Statistics}},\n  title        = {Business R\\&D Performance in the United States Increases to \\$722 Billion in 2023},\n  year         = {2023},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_VWSC69XR085KDC13XQAD65FJY0},\n  note         = {Original source: https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_MM257ZMAAREGBJJTTF3T73T6R0",
        "url": "https://statorigin.org/stat/stat_MM257ZMAAREGBJJTTF3T73T6R0",
        "indicator": {
          "slug": "pharmaceutical-and-medicine-manufacturing-r-d-funded-by-foreign-companies",
          "name": "Pharmaceutical and medicine manufacturing R&D funded by foreign companies",
          "definition": "Cost of research and development performed by pharmaceutical and medicine manufacturing companies that was paid for by foreign companies."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2023-01-01",
          "end": "2023-12-31",
          "type": "year"
        },
        "value": 9,
        "value_text": "$9 billion",
        "unit": "USD",
        "currency": "USD",
        "scale": "billion",
        "value_type": "actual",
        "source": {
          "org": "National Center for Science and Engineering Statistics",
          "org_short_name": "NCSES",
          "org_url": "https://ncses.nsf.gov",
          "org_tier": 1,
          "document_title": "Business R&D Performance in the United States Increases to $722 Billion in 2023",
          "document_url": "https://ncses.nsf.gov/pubs/nsf25353",
          "document_type": "press_release",
          "locator": "R&D Performance, by Type of R&D, Industry Sector, and Source of Funding",
          "quote": "Sixty-six percent of foreign company R&D funding went to three industry groups: pharmaceuticals and medicines (NAICS 3254) ($9 billion), scientific research and development services (NAICS 5417) ($4 billion), and computer and electronic products (NAICS 334) ($4 billion) (table 2).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "National Center for Science and Engineering Statistics. (2023). Business R&D Performance in the United States Increases to $722 Billion in 2023. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsf25353. Via StatOrigin, https://statorigin.org/stat/stat_MM257ZMAAREGBJJTTF3T73T6R0",
          "bibtex": "@misc{ncses2023pharmaceutical73t6r0,\n  author       = {{National Center for Science and Engineering Statistics}},\n  title        = {Business R\\&D Performance in the United States Increases to \\$722 Billion in 2023},\n  year         = {2023},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_MM257ZMAAREGBJJTTF3T73T6R0},\n  note         = {Original source: https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_1T62KC55PBN17E6MAPSH2EP2XC",
        "url": "https://statorigin.org/stat/stat_1T62KC55PBN17E6MAPSH2EP2XC",
        "indicator": {
          "slug": "pharmaceutical-and-medicine-manufacturing-r-d-funded-by-other-external-sources",
          "name": "Pharmaceutical and medicine manufacturing R&D funded by other external sources",
          "definition": "Cost of research and development performed by pharmaceutical and medicine manufacturing companies that was paid for by other external organizations."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2023-01-01",
          "end": "2023-12-31",
          "type": "year"
        },
        "value": 79,
        "value_text": "79",
        "unit": "USD",
        "currency": "USD",
        "scale": "million",
        "value_type": "actual",
        "source": {
          "org": "National Center for Science and Engineering Statistics",
          "org_short_name": "NCSES",
          "org_url": "https://ncses.nsf.gov",
          "org_tier": 1,
          "document_title": "Business R&D Performance in the United States Increases to $722 Billion in 2023",
          "document_url": "https://ncses.nsf.gov/pubs/nsf25353",
          "document_type": "press_release",
          "locator": "Table 2. Funds spent for business R&D performed in the United States, by source of funds, selected industry, and company size: 2023",
          "quote": "Pharmaceuticals and medicines, 3254 125,986 empty 114,225 empty 11,761 empty 549 empty 2,104 empty 9,029 empty 79 empty",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "National Center for Science and Engineering Statistics. (2023). Business R&D Performance in the United States Increases to $722 Billion in 2023. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsf25353. Via StatOrigin, https://statorigin.org/stat/stat_1T62KC55PBN17E6MAPSH2EP2XC",
          "bibtex": "@misc{ncses2023pharmaceutical2ep2xc,\n  author       = {{National Center for Science and Engineering Statistics}},\n  title        = {Business R\\&D Performance in the United States Increases to \\$722 Billion in 2023},\n  year         = {2023},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_1T62KC55PBN17E6MAPSH2EP2XC},\n  note         = {Original source: https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_Z8095B592EQK61Y451CQSEQD2M",
        "url": "https://statorigin.org/stat/stat_Z8095B592EQK61Y451CQSEQD2M",
        "indicator": {
          "slug": "pharmaceutical-and-medicine-manufacturing-r-d-intensity",
          "name": "Pharmaceutical and medicine manufacturing R&D intensity",
          "definition": "Ratio of research and development expenditures to net sales for pharmaceutical and medicine manufacturing companies."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2022-01-01",
          "end": "2022-12-31",
          "type": "year"
        },
        "value": 17,
        "value_text": "17%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "National Center for Science and Engineering Statistics",
          "org_short_name": "NCSES",
          "org_url": "https://ncses.nsf.gov",
          "org_tier": 1,
          "document_title": "Discovery: R&D Activity and Research Publications",
          "document_url": "https://ncses.nsf.gov/pubs/nsb20257/u-s-business-r-d",
          "document_type": "press_release",
          "locator": "Industries That Perform the Most U.S. Business R&D",
          "quote": "Notable components of these industries in terms of R&D intensities include scientific R&D services (29%), semiconductor and other electronic components manufacturing (24%), pharmaceuticals and medicines manufacturing (17%), and software publishers (14%).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "National Center for Science and Engineering Statistics. (2022). Discovery: R&D Activity and Research Publications. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsb20257/u-s-business-r-d. Via StatOrigin, https://statorigin.org/stat/stat_Z8095B592EQK61Y451CQSEQD2M",
          "bibtex": "@misc{ncses2022pharmaceuticalseqd2m,\n  author       = {{National Center for Science and Engineering Statistics}},\n  title        = {Discovery: R\\&D Activity and Research Publications},\n  year         = {2022},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_Z8095B592EQK61Y451CQSEQD2M},\n  note         = {Original source: https://ncses.nsf.gov/pubs/nsb20257/u-s-business-r-d. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_17HCGJQRHQMFY0Q8P3N1QQDKNA",
        "url": "https://statorigin.org/stat/stat_17HCGJQRHQMFY0Q8P3N1QQDKNA",
        "indicator": {
          "slug": "pharmaceutical-and-medicine-manufacturing-r-d-intensity",
          "name": "Pharmaceutical and medicine manufacturing R&D intensity",
          "definition": "Ratio of research and development expenditures to net sales for pharmaceutical and medicine manufacturing companies."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2023-01-01",
          "end": "2023-12-31",
          "type": "year"
        },
        "value": 17.8,
        "value_text": "17.8%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "National Center for Science and Engineering Statistics",
          "org_short_name": "NCSES",
          "org_url": "https://ncses.nsf.gov",
          "org_tier": 1,
          "document_title": "Business R&D Performance in the United States Increases to $722 Billion in 2023",
          "document_url": "https://ncses.nsf.gov/pubs/nsf25353",
          "document_type": "press_release",
          "locator": "Sales, R&D Intensity, and Employment of Companies That Performed or Funded R&D",
          "quote": "Manufacturing industries with high levels of R&D intensity in 2023 were semiconductor and other electronic products (NAICS 3344) (25.8%) and pharmaceuticals and medicines (NAICS 3254) (17.8%).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "National Center for Science and Engineering Statistics. (2023). Business R&D Performance in the United States Increases to $722 Billion in 2023. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsf25353. Via StatOrigin, https://statorigin.org/stat/stat_17HCGJQRHQMFY0Q8P3N1QQDKNA",
          "bibtex": "@misc{ncses2023pharmaceuticalqqdkna,\n  author       = {{National Center for Science and Engineering Statistics}},\n  title        = {Business R\\&D Performance in the United States Increases to \\$722 Billion in 2023},\n  year         = {2023},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_17HCGJQRHQMFY0Q8P3N1QQDKNA},\n  note         = {Original source: https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_0QMFAF1MGRT1XPHY10KD7TPG9E",
        "url": "https://statorigin.org/stat/stat_0QMFAF1MGRT1XPHY10KD7TPG9E",
        "indicator": {
          "slug": "pharmaceutical-and-medicine-manufacturing-company-funded-r-d",
          "name": "Pharmaceutical and medicine manufacturing company-funded R&D",
          "definition": "Cost of research and development paid for and performed by pharmaceutical and medicine manufacturing companies."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2023-01-01",
          "end": "2023-12-31",
          "type": "year"
        },
        "value": 114225,
        "value_text": "114,225",
        "unit": "USD",
        "currency": "USD",
        "scale": "million",
        "value_type": "actual",
        "source": {
          "org": "National Center for Science and Engineering Statistics",
          "org_short_name": "NCSES",
          "org_url": "https://ncses.nsf.gov",
          "org_tier": 1,
          "document_title": "Business R&D Performance in the United States Increases to $722 Billion in 2023",
          "document_url": "https://ncses.nsf.gov/pubs/nsf25353",
          "document_type": "press_release",
          "locator": "Table 2. Funds spent for business R&D performed in the United States, by source of funds, selected industry, and company size: 2023",
          "quote": "Pharmaceuticals and medicines, 3254 125,986 empty 114,225 empty 11,761 empty 549 empty 2,104 empty 9,029 empty 79 empty",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "National Center for Science and Engineering Statistics. (2023). Business R&D Performance in the United States Increases to $722 Billion in 2023. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsf25353. Via StatOrigin, https://statorigin.org/stat/stat_0QMFAF1MGRT1XPHY10KD7TPG9E",
          "bibtex": "@misc{ncses2023pharmaceutical7tpg9e,\n  author       = {{National Center for Science and Engineering Statistics}},\n  title        = {Business R\\&D Performance in the United States Increases to \\$722 Billion in 2023},\n  year         = {2023},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_0QMFAF1MGRT1XPHY10KD7TPG9E},\n  note         = {Original source: https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_XJ3Y0628K87DZVSZ3M698Z8EVC",
        "url": "https://statorigin.org/stat/stat_XJ3Y0628K87DZVSZ3M698Z8EVC",
        "indicator": {
          "slug": "pharmaceutical-and-medicine-manufacturing-externally-funded-r-d",
          "name": "Pharmaceutical and medicine manufacturing externally funded R&D",
          "definition": "Total cost of research and development performed by pharmaceutical and medicine manufacturing companies that was paid for by outside sources."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2023-01-01",
          "end": "2023-12-31",
          "type": "year"
        },
        "value": 11761,
        "value_text": "11,761",
        "unit": "USD",
        "currency": "USD",
        "scale": "million",
        "value_type": "actual",
        "source": {
          "org": "National Center for Science and Engineering Statistics",
          "org_short_name": "NCSES",
          "org_url": "https://ncses.nsf.gov",
          "org_tier": 1,
          "document_title": "Business R&D Performance in the United States Increases to $722 Billion in 2023",
          "document_url": "https://ncses.nsf.gov/pubs/nsf25353",
          "document_type": "press_release",
          "locator": "Table 2. Funds spent for business R&D performed in the United States, by source of funds, selected industry, and company size: 2023",
          "quote": "Pharmaceuticals and medicines, 3254 125,986 empty 114,225 empty 11,761 empty 549 empty 2,104 empty 9,029 empty 79 empty",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "National Center for Science and Engineering Statistics. (2023). Business R&D Performance in the United States Increases to $722 Billion in 2023. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsf25353. Via StatOrigin, https://statorigin.org/stat/stat_XJ3Y0628K87DZVSZ3M698Z8EVC",
          "bibtex": "@misc{ncses2023pharmaceutical8z8evc,\n  author       = {{National Center for Science and Engineering Statistics}},\n  title        = {Business R\\&D Performance in the United States Increases to \\$722 Billion in 2023},\n  year         = {2023},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_XJ3Y0628K87DZVSZ3M698Z8EVC},\n  note         = {Original source: https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_AN95JY586K083ZAY5TY48GEH6C",
        "url": "https://statorigin.org/stat/stat_AN95JY586K083ZAY5TY48GEH6C",
        "indicator": {
          "slug": "pharmaceutical-and-medicine-manufacturing-government-funded-r-d",
          "name": "Pharmaceutical and medicine manufacturing government-funded R&D",
          "definition": "Cost of research and development performed by pharmaceutical and medicine manufacturing companies that was paid for by the government."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2023-01-01",
          "end": "2023-12-31",
          "type": "year"
        },
        "value": 549,
        "value_text": "549",
        "unit": "USD",
        "currency": "USD",
        "scale": "million",
        "value_type": "actual",
        "source": {
          "org": "National Center for Science and Engineering Statistics",
          "org_short_name": "NCSES",
          "org_url": "https://ncses.nsf.gov",
          "org_tier": 1,
          "document_title": "Business R&D Performance in the United States Increases to $722 Billion in 2023",
          "document_url": "https://ncses.nsf.gov/pubs/nsf25353",
          "document_type": "press_release",
          "locator": "Table 2. Funds spent for business R&D performed in the United States, by source of funds, selected industry, and company size: 2023",
          "quote": "Pharmaceuticals and medicines, 3254 125,986 empty 114,225 empty 11,761 empty 549 empty 2,104 empty 9,029 empty 79 empty",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "National Center for Science and Engineering Statistics. (2023). Business R&D Performance in the United States Increases to $722 Billion in 2023. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsf25353. Via StatOrigin, https://statorigin.org/stat/stat_AN95JY586K083ZAY5TY48GEH6C",
          "bibtex": "@misc{ncses2023pharmaceutical8geh6c,\n  author       = {{National Center for Science and Engineering Statistics}},\n  title        = {Business R\\&D Performance in the United States Increases to \\$722 Billion in 2023},\n  year         = {2023},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_AN95JY586K083ZAY5TY48GEH6C},\n  note         = {Original source: https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_WCZV2YCDY3JNKHXX6BRQGQVZZ7",
        "url": "https://statorigin.org/stat/stat_WCZV2YCDY3JNKHXX6BRQGQVZZ7",
        "indicator": {
          "slug": "pharmaceutical-and-medicine-manufacturing-net-sales",
          "name": "Pharmaceutical and medicine manufacturing net sales",
          "definition": "Net sales of goods sold or services rendered by pharmaceutical and medicine manufacturing companies."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2022-01-01",
          "end": "2022-12-31",
          "type": "year"
        },
        "value": 685744,
        "value_text": "685,744",
        "unit": "USD",
        "currency": "USD",
        "scale": "million",
        "value_type": "actual",
        "source": {
          "org": "National Center for Science and Engineering Statistics",
          "org_short_name": "NCSES",
          "org_url": "https://ncses.nsf.gov",
          "org_tier": 1,
          "document_title": "Discovery: R&D Activity and Research Publications",
          "document_url": "https://ncses.nsf.gov/pubs/nsb20257/u-s-business-r-d",
          "document_type": "press_release",
          "locator": "Table DISC-3. Domestic net sales, R&D, and R&D-to-sales ratio for companies that performed or funded U.S. business R&D, by selected industry: 2022",
          "quote": "Pharmaceuticals and medicines, 3254 685,744 116,073 16.9",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "National Center for Science and Engineering Statistics. (2022). Discovery: R&D Activity and Research Publications. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsb20257/u-s-business-r-d. Via StatOrigin, https://statorigin.org/stat/stat_WCZV2YCDY3JNKHXX6BRQGQVZZ7",
          "bibtex": "@misc{ncses2022pharmaceuticalgqvzz7,\n  author       = {{National Center for Science and Engineering Statistics}},\n  title        = {Discovery: R\\&D Activity and Research Publications},\n  year         = {2022},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_WCZV2YCDY3JNKHXX6BRQGQVZZ7},\n  note         = {Original source: https://ncses.nsf.gov/pubs/nsb20257/u-s-business-r-d. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_60NBQP5FNDQHVD0J0KSR2WR1GF",
        "url": "https://statorigin.org/stat/stat_60NBQP5FNDQHVD0J0KSR2WR1GF",
        "indicator": {
          "slug": "pharmaceutical-and-medicine-manufacturing-total-r-d-performance",
          "name": "Pharmaceutical and medicine manufacturing total R&D performance",
          "definition": "Total cost of research and development performed by pharmaceutical and medicine manufacturing companies across all funding sources."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2022-01-01",
          "end": "2022-12-31",
          "type": "year"
        },
        "value": 116073,
        "value_text": "116,073",
        "unit": "USD",
        "currency": "USD",
        "scale": "million",
        "value_type": "actual",
        "source": {
          "org": "National Center for Science and Engineering Statistics",
          "org_short_name": "NCSES",
          "org_url": "https://ncses.nsf.gov",
          "org_tier": 1,
          "document_title": "Discovery: R&D Activity and Research Publications",
          "document_url": "https://ncses.nsf.gov/pubs/nsb20257/u-s-business-r-d",
          "document_type": "press_release",
          "locator": "Table DISC-3. Domestic net sales, R&D, and R&D-to-sales ratio for companies that performed or funded U.S. business R&D, by selected industry: 2022",
          "quote": "Pharmaceuticals and medicines, 3254 685,744 116,073 16.9",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "National Center for Science and Engineering Statistics. (2022). Discovery: R&D Activity and Research Publications. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsb20257/u-s-business-r-d. Via StatOrigin, https://statorigin.org/stat/stat_60NBQP5FNDQHVD0J0KSR2WR1GF",
          "bibtex": "@misc{ncses2022pharmaceutical2wr1gf,\n  author       = {{National Center for Science and Engineering Statistics}},\n  title        = {Discovery: R\\&D Activity and Research Publications},\n  year         = {2022},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_60NBQP5FNDQHVD0J0KSR2WR1GF},\n  note         = {Original source: https://ncses.nsf.gov/pubs/nsb20257/u-s-business-r-d. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_N0XT8MYSWQX4EXP732TCPJBRXV",
        "url": "https://statorigin.org/stat/stat_N0XT8MYSWQX4EXP732TCPJBRXV",
        "indicator": {
          "slug": "pharmaceutical-and-medicine-manufacturing-total-r-d-performance",
          "name": "Pharmaceutical and medicine manufacturing total R&D performance",
          "definition": "Total cost of research and development performed by pharmaceutical and medicine manufacturing companies across all funding sources."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2023-01-01",
          "end": "2023-12-31",
          "type": "year"
        },
        "value": 125986,
        "value_text": "125,986",
        "unit": "USD",
        "currency": "USD",
        "scale": "million",
        "value_type": "actual",
        "source": {
          "org": "National Center for Science and Engineering Statistics",
          "org_short_name": "NCSES",
          "org_url": "https://ncses.nsf.gov",
          "org_tier": 1,
          "document_title": "Business R&D Performance in the United States Increases to $722 Billion in 2023",
          "document_url": "https://ncses.nsf.gov/pubs/nsf25353",
          "document_type": "press_release",
          "locator": "Table 2. Funds spent for business R&D performed in the United States, by source of funds, selected industry, and company size: 2023",
          "quote": "Pharmaceuticals and medicines, 3254 125,986 empty 114,225 empty 11,761 empty 549 empty 2,104 empty 9,029 empty 79 empty",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "National Center for Science and Engineering Statistics. (2023). Business R&D Performance in the United States Increases to $722 Billion in 2023. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsf25353. Via StatOrigin, https://statorigin.org/stat/stat_N0XT8MYSWQX4EXP732TCPJBRXV",
          "bibtex": "@misc{ncses2023pharmaceuticalpjbrxv,\n  author       = {{National Center for Science and Engineering Statistics}},\n  title        = {Business R\\&D Performance in the United States Increases to \\$722 Billion in 2023},\n  year         = {2023},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_N0XT8MYSWQX4EXP732TCPJBRXV},\n  note         = {Original source: https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      }
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 11,
    "note": "Statistics are capped at 100 per request. Use /statistics?source_org=national-center-for-science-and-engineering-statistics with a cursor to page through everything."
  }
}